Document Detail
Research Title: READ-2 Study - Ranibizumab (Lucentis) alone vs. combination with laser photocoagulation for Diabetic Macular Edema. Phase 2
Investigators: John S. Pollack, M.D., Principal Investigator
Description: To determine whether dose interval of Ranibizumab (Lucentis) alone or in combination with Laser produce a greater benefit for Diabetic Macular Edema
Start Date: 01/01/07
Recruitment: Open
Project Personnel: Barb C.
Location(s): Illinois Retina Associates, S.C., 300 Barney Drive #D, Joliet, IL 60435
|